BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 25006242)

  • 1. Retinoblastoma protein and MyoD function together to effect the repression of Fra-1 and in turn cyclin D1 during terminal cell cycle arrest associated with myogenesis.
    Rajabi HN; Takahashi C; Ewen ME
    J Biol Chem; 2014 Aug; 289(34):23417-27. PubMed ID: 25006242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coupling of the cell cycle and myogenesis through the cyclin D1-dependent interaction of MyoD with cdk4.
    Zhang JM; Wei Q; Zhao X; Paterson BM
    EMBO J; 1999 Feb; 18(4):926-33. PubMed ID: 10022835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct inhibition of G(1) cdk kinase activity by MyoD promotes myoblast cell cycle withdrawal and terminal differentiation.
    Zhang JM; Zhao X; Wei Q; Paterson BM
    EMBO J; 1999 Dec; 18(24):6983-93. PubMed ID: 10601020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. pRb is required for MEF2-dependent gene expression as well as cell-cycle arrest during skeletal muscle differentiation.
    Novitch BG; Spicer DB; Kim PS; Cheung WL; Lassar AB
    Curr Biol; 1999 May; 9(9):449-59. PubMed ID: 10322110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An extracellular signal-regulated kinase 1- and 2-dependent program of chromatin trafficking of c-Fos and Fra-1 is required for cyclin D1 expression during cell cycle reentry.
    Burch PM; Yuan Z; Loonen A; Heintz NH
    Mol Cell Biol; 2004 Jun; 24(11):4696-709. PubMed ID: 15143165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD.
    Halevy O; Novitch BG; Spicer DB; Skapek SX; Rhee J; Hannon GJ; Beach D; Lassar AB
    Science; 1995 Feb; 267(5200):1018-21. PubMed ID: 7863327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MyoD can induce cell cycle arrest but not muscle differentiation in the presence of dominant negative SWI/SNF chromatin remodeling enzymes.
    de la Serna IL; Roy K; Carlson KA; Imbalzano AN
    J Biol Chem; 2001 Nov; 276(44):41486-91. PubMed ID: 11522799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skeletal muscle cells lacking the retinoblastoma protein display defects in muscle gene expression and accumulate in S and G2 phases of the cell cycle.
    Novitch BG; Mulligan GJ; Jacks T; Lassar AB
    J Cell Biol; 1996 Oct; 135(2):441-56. PubMed ID: 8896600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclin-mediated inhibition of muscle gene expression via a mechanism that is independent of pRB hyperphosphorylation.
    Skapek SX; Rhee J; Kim PS; Novitch BG; Lassar AB
    Mol Cell Biol; 1996 Dec; 16(12):7043-53. PubMed ID: 8943359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Class I histone deacetylases sequentially interact with MyoD and pRb during skeletal myogenesis.
    Puri PL; Iezzi S; Stiegler P; Chen TT; Schiltz RL; Muscat GE; Giordano A; Kedes L; Wang JY; Sartorelli V
    Mol Cell; 2001 Oct; 8(4):885-97. PubMed ID: 11684023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation.
    Gu W; Schneider JW; Condorelli G; Kaushal S; Mahdavi V; Nadal-Ginard B
    Cell; 1993 Feb; 72(3):309-24. PubMed ID: 8381715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Id2 specifically alters regulation of the cell cycle by tumor suppressor proteins.
    Lasorella A; Iavarone A; Israel MA
    Mol Cell Biol; 1996 Jun; 16(6):2570-8. PubMed ID: 8649364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct interaction of p21 cyclin-dependent kinase inhibitor with the retinoblastoma tumor suppressor protein.
    Nakanishi M; Kaneko Y; Matsushime H; Ikeda K
    Biochem Biophys Res Commun; 1999 Sep; 263(1):35-40. PubMed ID: 10486249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel E1A domain mediates skeletal-muscle-specific enhancer repression independently of pRB and p300 binding.
    Sandmöller A; Meents H; Arnold HH
    Mol Cell Biol; 1996 Oct; 16(10):5846-56. PubMed ID: 8816499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MyoD induces apoptosis in the absence of RB function through a p21(WAF1)-dependent re-localization of cyclin/cdk complexes to the nucleus.
    Peschiaroli A; Figliola R; Coltella L; Strom A; Valentini A; D'Agnano I; Maione R
    Oncogene; 2002 Nov; 21(53):8114-27. PubMed ID: 12444547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p300 is required for MyoD-dependent cell cycle arrest and muscle-specific gene transcription.
    Puri PL; Avantaggiati ML; Balsano C; Sang N; Graessmann A; Giordano A; Levrero M
    EMBO J; 1997 Jan; 16(2):369-83. PubMed ID: 9029156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of myostatin reduces MyoD induced myogenic potential of primary muscle fibroblasts.
    Shenoy P S; Bose B; Sharma M; McFarlane C; Kambadur R
    J Cell Biochem; 2014 Nov; 115(11):1908-17. PubMed ID: 24909401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ectopic expression of cyclin D1 prevents activation of gene transcription by myogenic basic helix-loop-helix regulators.
    Rao SS; Chu C; Kohtz DS
    Mol Cell Biol; 1994 Aug; 14(8):5259-67. PubMed ID: 8035804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutagenesis of the pRB pocket reveals that cell cycle arrest functions are separable from binding to viral oncoproteins.
    Dick FA; Sailhamer E; Dyson NJ
    Mol Cell Biol; 2000 May; 20(10):3715-27. PubMed ID: 10779361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA tumor virus oncoproteins and retinoblastoma gene mutations share the ability to relieve the cell's requirement for cyclin D1 function in G1.
    Lukas J; Müller H; Bartkova J; Spitkovsky D; Kjerulff AA; Jansen-Dürr P; Strauss M; Bartek J
    J Cell Biol; 1994 May; 125(3):625-38. PubMed ID: 8175885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.